Navigation Links
BIOCOM's 4th Annual DeviceFest Honors Companies
Date:5/12/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Express Scripts, Inc. (Nasdaq: ESRX ), ... companies in North America, announced today results ... of seizure risk among epilepsy patients after ... study found no evidence that switching between ... substitution, was associated with increased emergency room ...
(Date:12/17/2009)... -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX ) ... Vice President, Sales and Commercial Affairs. In ... will be responsible for all commercial activities, including ... accordance with the collaboration agreement between the Company ... products that emerge from the Company,s pipeline. ...
(Date:12/16/2009)... Dec. 17 Cell Therapeutics, Inc. ... that on February 10, 2010 the U.S. ... Committee (ODAC) will review the New Drug ... of relapsed/refractory aggressive non-Hodgkin,s lymphoma (NHL). ODAC ... evaluates data concerning the efficacy and safety ...
Breaking Medicine Technology:Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 1Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 2Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 3Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 4Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 5Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 6Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 7Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 8LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 1LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 2ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 1ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 2
... , - Novel Treatment Also Demonstrated ... in Depressive Symptoms, Positive data from ... the 8th,European Congress of Epileptology, Berlin, Germany, ... once daily,anti-epileptic agent, significantly reduced the frequency ...
... shows high prevalence of "bothersome" vaginal atrophy, symptoms among ... today at 19th Annual North American Menopause ... ... results of a,Phase 3 study for Ophena(TM) (ospemifene tablets) for the ...
Other Medicine Technology:New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 2New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 3New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 4New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 5New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 6QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4
(Date:12/17/2009)... AlloSource, one of the nation,s largest non-profit providers of ... surgical procedures and the world,s largest processor of live ... been selected as a finalist in the 2010 Colorado ... Institute category honoring non-profits. This is the second year ... a finalist by the annual awards program, now in ...
(Date:12/17/2009)... A new study shows the employment and sociodemographic characteristics ... hazards. Of these, 56% say they often work standing ... exposed to workplace stress and 62% say they are ... of work. , "Pregnant and breastfeeding women are especially ... lead author of the study and a researcher at ...
(Date:12/17/2009)... DIEGO (December 17, 2009) Researchers from the ... aim at several of the world,s most dangerous infectious ... a five-year, $18.8 million federally-funded set of projects seeking ... , The Institute received four project awards ... and Infectious Diseases (NIAID), part of the National Institutes ...
(Date:12/17/2009)... Conference in Copenhagen approaches its conclusion, negotiations are ... climate change. The new ,Reducing Emissions from Deforestation ... as a central element of any new agreement. ... global greenhouse gas emissions, this new policy would ... to emissions reduction. Linked to this, developed countries ...
(Date:12/17/2009)... Stories of Inspiration on How Exercise Has Helped, Healed, and Preserved ... ... -- The International Health, Racquet & Sportsclub Association (IHRSA) announced today ... is urging Americans of all ages and abilities to make 2010 ... culture of movement in America wherein regular daily exercise is highly ...
Breaking Medicine News(10 mins):Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3Health News:Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5Health News:Forests take center stage at Copenhagen 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5
... Association (HIVMA) is celebrating the good news from the ... global case count is lower than previous estimates. However, ... by President Bushs veto of the annual funding bill ... that have faced stagnant funding throughout the Bush administration ...
... boosting fiber intake can help lower the odds, researchers say , ... women who ate foods high on the glycemic index -- which ... at increased risk for developing type 2 diabetes, two new ... that eating more cereal fiber may be associated with a reduced ...
... the popular class of drugs used to lower cholesterol, ... countries. But for some patients, accompanying side effects of ... rare cases, can escalate to debilitating and even life-threatening ... Beth Israel Deaconess Medical Center (BIDMC), helps explain the ...
... Proven Probiotic to Store Shelves, CINCINNATI, Nov. 27 ... probiotic supplement new to store shelves, will now,be sold ... daily probiotic,supplement -- a source of healthy bacteria that ... of episodic digestive upsets, such as,constipation, diarrhea, abdominal discomfort, ...
... Open Up The Inner World Of Rehab As They Help Nine ... Premiere on VH1 on January 10, 2008 at 10pm With Eight ... One-Hour Episodes, NEW YORK, ... with Dr. Drew." The project, consisting,of eight one-hour episodes, is slated to premiere on ...
... announced this years Open Senior,Division winner in the ... was one of five participants in the Open ... researchers from the Prince of,Wales Hospital and colleagues ... her studies, UNSW PhD student Ms Bachmann,presented the ...
Other Medicine News:Health News:World AIDS Day: Seeking leadership from the Bush Administration 2Health News:High-Carb Diet Raises Women's Diabetes Risk 2Health News:Scientists identify gene responsible for statin-induced muscle pain 2Health News:Scientists identify gene responsible for statin-induced muscle pain 3Health News:Dallas Among the First to Offer Probiotic Supplement Align(R) 2Health News:Dallas Among the First to Offer Probiotic Supplement Align(R) 3Health News:VH1 Teams Up with Dr. Drew for 'Celebrity Rehab With Dr. Drew,' a Series Depicting the Process of Overcoming Addiction 2Health News:VH1 Teams Up with Dr. Drew for 'Celebrity Rehab With Dr. Drew,' a Series Depicting the Process of Overcoming Addiction 3
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... VasoSeal VHD was ... rapidly stop bleeding after ... and radiology procedures. It ... sealing device approved for ...
... collagen hemostat. FirstStop is a non-friable, non-woven ... characteristics. It can easily be cut to ... FirstStop products are not dispersed when wet ... hemostasis is achieved. As the collagen forms ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
Medicine Products: